Clinical and Medico-economic Evaluation of Taken Care Associating Nutritional Support and Adapted Physical Activity for Malnourished, or at Risk of Undernutrition, Elderly People on Discharge From Hospital
NCT ID: NCT03979560
Last Updated: 2023-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
47 participants
INTERVENTIONAL
2019-06-28
2021-12-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized Dietary Advice After Discharge From Hospital in Geriatrics: Factors Associated With Improved Nutritional Status and Autonomy
NCT04016532
Assessment of Food Practices by Residents in Nursing Homes
NCT02626078
Nutritional Intervention in Geriatric Patients
NCT03131856
Developing and Implementing Meaningful Activities Facilitators in Geriatric Short Stay
NCT06080126
Effectiveness of the Jeanne et Léon Program® on the Residents's Frailty in Temporary
NCT05659706
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Population of interest:
* Older people at least 70 years, malnourished or at risk of malnutrition, on discharge from hospital
* Informal caregivers of patients included in study
Intervention at home of professionals:
Mixed intervention: nutritional support, carried out by the dieticians of " Saveurs et Vie ", in seven sessions over three months, combined with an adapted physical activity intervention (APA), carried out by " Siel Bleu " professionals, also at a frequency of seven sessions over three months, for a total of fourteen sessions.
Control arm will benefit from usual support (depending on practices of the department, prescription or not of oral nutritional supplements and physiotherapy at home, but without home intervention of adapted physical activity professionals or dieticians).
In addition to screening/inclusion visits (D0), three follow-up home visits are scheduled at D7, D45 and D90 for both study groups.
Inclusion visit (D0), performed in hospital in geriatric ward prior to hospital discharge. Verification of inclusion criteria, collection of consent by investigator, randomization, collection of inclusion data (socio-educational level, family status, assessment of autonomy (ADL, IADL, AGGIR) number of drugs, comorbidity (CIRS-G), cognitive status, biology performed during hospitalization (albumin, CRP, Vitamin D) and discharge prescription (NOC, nutritional advice, physiotherapy) are programmed to D7, D45 and D90 for both study arms.
Follow-up visits to D7, D45 and D90, carried out at home by a clinal research technician mandated by sponsor (Gérond'if). Assessment of autonomy (ADL, IADL, AGGIR scale), nutritional status (weight, height, self-evaluation of appetite, MNA), functional status (Grinding strength, 4-metre walking speed, SPPB), quality of life (EQ-5D), frequency and transit time of home help workers, whether family or professional. Acceptability of interventions for the home intervention arm.
2 patient/arms, a total of 372 patients divided as follows:
* Interventional arm : Nutrition intervention with appropriate physical activity for 186 patients
* Control arm: standard care for 186 other patients And up to 160 informal caregivers (family members) in both groups, or 80 caregivers per group (one caregiver per patient).
Inclusion period: 15 months. Follow-up period: 3 months/subject (patients and caregivers) Total length of study: 18 months
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The control group will benefit from the usual support (depending on the practices of the department, prescription or not of oral nutritional supplements and physiotherapy at home, but without home intervention of adapted physical activity professionals or dieticians).
In addition to screening/inclusion visits (D0), three follow-up home visits are scheduled at D7, D45 and D90 for both study groups.
No interventions assigned to this group
Nutrition intervention with appropriate physical activity
Intervention at home of professionals:
Patients in this arm will benefit from 14 home interventions
* 7 home nutrition support (NS) sessions in 3 months or 1 session every 10 days (+/-4 days). These sessions will be conducted by a dietician from the company "Saveurs et Vie".
* 7 home sessions of adaptive physical activity (APA) in 3 months, one session every 10 days (+/-4 days). These sessions will be conducted by professionals from association group "Siel Bleu".
In addition to screening/inclusion visits (D0), three follow-up home visits are scheduled at D7, D45 and D90 for both study groups.
Intervention
Nutritional support in seven sessions spread over three months, combined with an adapted physical activity intervention (APA), also at a frequency of seven sessions spread over three months, or fourteen home sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
Nutritional support in seven sessions spread over three months, combined with an adapted physical activity intervention (APA), also at a frequency of seven sessions spread over three months, or fourteen home sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalized in acute geriatrics (UGA), with expected return to home directly after the UGA
* Undernourished or at risk of undernutrition (MNA SF12)
* Able to walk 4 metres without third party assistance
* Able to understand and consent to the study
* Good understanding of the French language
* Living in Paris (department 75)
* Patient affiliated with a social security scheme
* Having read the information note and having agreed to participate in the study by signing the consent.
Exclusion Criteria
* Chronic inflammatory pathology
* Progressive cancer
* Severe renal failure (creatinine clearance \< 30ml/min/1.73 m2)
* NYHA Stage III or IV Dyspnea
* Chronic respiratory failure (oxygen therapy at home)
* Liver failure (TP \< 50%)
* Severe depression
* severe dementia, according to DSM V criteria
* swallowing disorders with inhalation pneumonia
* corticosteroids (\> 10 mg prednisone/day long-term or equivalent)
* Systolic blood pressure \>200 mmHg
* Unstabilized acute coronary syndrome
* decompensated heart failure
* Severe, uncontrolled ventricular rhythm disorders
* High risk embolic intracardiac thrombus
* Presence of medium to large pericardial effusion
* Recent history of thrombophlebitis with or without pulmonary embolism
* Obstacle to severe and/or symptomatic left ventricular ejection
* Severe and symptomatic pulmonary hypertension
* Inability to perform appropriate physical activities
* Subject participating or having participated in a therapeutic trial within the last 3 months
* Refusal to participate
* Person under guardianship, guardianship or safeguard of justice
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gérond'if
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Département de Gériatrie, Hôpital Bichat
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02973-50
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.